Versant Venture Capital V L.P. 13D/13G Filings for Turnstone Biologics Corp. (TSBX)

Versant Venture Capital V L.P. 13D and 13G filings for Turnstone Biologics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-08-03
4:41 pm
Purchase
2023-07-2513DTurnstone Biologics Corp.
TSBX
Versant Venture Capital V L.P.2,899,216
12.500%
2,899,216increase
(New Position)
Filing